ARTICLE | Company News
Labopharm, Aventis deal
November 19, 2001 8:00 AM UTC
DDS licensed its Contramid extended release formulation technology to AVE for use developing once-a-day formulations of AVE's Allegra-D fexofenadine to treat seasonal allergic rhinitis. DDS will recei...